(Q33221066)

24 July 2017

title

Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40. (English)

1 reference

24 July 2017

0 references

Woojin Kim

1

1 reference

24 July 2017

Michael H Hecht

series ordinal

2

1 reference

24 July 2017

language of work or name

English

0 references

publication date

3 August 2005

1 reference

Journal of Biological Chemistry

24 July 2017

published in

1 reference

24 July 2017

volume

280

1 reference

24 July 2017

issue

41

1 reference

24 July 2017

page(s)

35069-35076

1 reference

Amyloid diseases: abnormal protein aggregation in neurodegeneration

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

21 January 2018

Conformational disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Defective protein folding as a basis of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

The molecular pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Use of T7 RNA polymerase to direct expression of cloned genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

A simple method for displaying the hydropathic character of a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Rationalization of the effects of mutations on peptide and protein aggregation rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Understanding, improving and using green fluorescent proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

De novo proteins from designed combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Alzheimer's amyloid fibrils: structure and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Molecular basis for amyloid fibril formation and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Proteolytic generation and aggregation of peptides from transmembrane regions: lung surfactant protein C and amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Stabilization of discordant helices in amyloid fibril-forming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Prediction of amyloid fibril-forming proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Rapid protein-folding assay using green fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid β-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Thioflavine T interaction with amyloid β-sheet structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

Measurement of the β-sheet-forming propensities of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M505763200

21 January 2018

Identifiers

DOI

10.1074/JBC.M505763200

1 reference

24 July 2017

1 reference